Open Side Menu
Skip to contentBrand Logo
Categories
Groups
News and eventsBCNA websiteHelpline: 1800 500 258
RegisterSign In

PBS

3 Posts

  1. BCNA Online Network
  2. Policy & advocacy for breast cancer
  3. PBS

Forum Widgets

Recent Discussions

  • 🔔 Update on access to Zoladex treatment

    We heard your concerns about AstraZeneca's decision to discontinue Zoladex 3.6mg from 1 November 2026 - and we went to work on your behalf. After coordinating advocacy with clinicians, consum...
    Mez_BCNA
    19 days ago
    advocacy
    news
    treatment
    zoladex
    57Views
    4likes
    0Comments
  • Aligning PBS Policy with Contemporary HER2-Positive Metastatic Breast Cancer Care

    I am concerned about a structural problem in how HER2-positive metastatic breast cancer is managed under current PBS rules. Patients who achieve an excellent response to T-DM1 or T-DXd cannot step d...
    kabash
    2 months ago
    41Views
    3likes
    1Comment
  • 📢 Capivasertib (Truqap) to be listed on the PBS!

    The Australian Government has announced that as of 1 October capivasertib (Truqap) will be listed on the Pharmacetucial Benefits Scheme (PBS), providing another vital option for Australians with ...
    Christina_BCNA
    7 months ago
    medication
    metastatic breast cancer
    PBS
    39Views
    2likes
    0Comments

Tags

  • medication1 Topic
  • metastatic breast cancer1 Topic
  • PBS1 Topic
  • treatment1 Topic
  • zoladex1 Topic
  • advocacy1 Topic
  • news1 Topic

Community home |  Community guidelines | Terms of use | Our partners

FOUNDATION PARTNER

Foundation partner - Bakers Delight
PRINCIPAL PARTNER

Principal partner - Red Energy
MAJOR PARTNERS

Major partner - Berlei
Major partner - Sussan
Disclaimer:
The information available on the Breast Cancer Network Australia website is not medical advice and is provided for information purposes only. It should not be viewed as a replacement for a consultation with a qualified medical professional. Our website is designed to offer information and support to the general public. Be aware that we do not provide any medical advice, and for medical advice we recommend you speak to a qualified medical professional or doctor.